Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure

This multicentre, randomised phase III study compared docetaxel with 5-fluorouracil+vinorelbine in patients with metastatic breast cancer after failure of neo/adjuvant or one line of palliative anthracycline-based chemotherapy. One hundred and seventy-six metastatic breast cancer patients were rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonneterre, J, Roché, H, Monnier, A, Guastalla, J P, Namer, M, Fargeot, P, Assadourian, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408916/
https://www.ncbi.nlm.nih.gov/pubmed/12439707
http://dx.doi.org/10.1038/sj.bjc.6600645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408916/
https://www.ncbi.nlm.nih.gov/pubmed/12439707
http://dx.doi.org/10.1038/sj.bjc.6600645

Ejemplares similares